tizanidine
Generic: tizanidine
Labeler: direct_rxDrug Facts
Product Profile
Brand Name
tizanidine
Generic Name
tizanidine
Labeler
direct_rx
Dosage Form
TABLET
Routes
Active Ingredients
tizanidine hydrochloride 4 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72189-602
Product ID
72189-602_2d4108dc-4f74-69fb-e063-6294a90a10f8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076416
Listing Expiration
2026-12-31
Marketing Start
2024-12-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72189602
Hyphenated Format
72189-602
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tizanidine (source: ndc)
Generic Name
tizanidine (source: ndc)
Application Number
ANDA076416 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (72189-602-30)
- 60 TABLET in 1 BOTTLE (72189-602-60)
- 90 TABLET in 1 BOTTLE (72189-602-90)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2d4108dc-4f74-69fb-e063-6294a90a10f8", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["2a91884a-39c3-f7ac-e063-6394a90ade14"], "manufacturer_name": ["Direct_rx"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72189-602-30)", "package_ndc": "72189-602-30", "marketing_start_date": "20241231"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (72189-602-60)", "package_ndc": "72189-602-60", "marketing_start_date": "20241231"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (72189-602-90)", "package_ndc": "72189-602-90", "marketing_start_date": "20241231"}], "brand_name": "Tizanidine", "product_id": "72189-602_2d4108dc-4f74-69fb-e063-6294a90a10f8", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "72189-602", "generic_name": "Tizanidine", "labeler_name": "Direct_rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076416", "marketing_category": "ANDA", "marketing_start_date": "20241231", "listing_expiration_date": "20261231"}